TerminatedPHASE1, PHASE2NCT01194674

Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema

Studying Uveitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institutes of Health Clinical Center (CC)
Principal Investigator
Hatice Nida Sen, MD, MHSc
National Institutes of Health (NIH)
Intervention
Microplasmin(drug)
Enrollment
2 target
Eligibility
18 years · All sexes
Timeline
20112011

Study locations (1)

Collaborators

National Eye Institute (NEI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01194674 on ClinicalTrials.gov

Other trials for Uveitis

Additional recruiting or active studies for the same condition.

See all trials for Uveitis

← Back to all trials